Public Health awaiting peer review of study
The Isle of Man will not change its vaccination programme despite concerns about the South African variant of Covid-19.
It’s after reports suggest the Oxford-AstraZeneca vaccine may only offer limited protection from a mild to moderate strain of the new variant.
Public Health says the study – which only had 2,000 participants with an average age of 31 - still requires peer review.
Until that happens it says the current position is that the jab does protect against the predominant Covid variants currently circulating so there is ‘no reason to change’.
Smile of Mann programme to start in primary schools next year
Loganair passengers yet to be reunited with bags left in Manchester on Sunday
Kirk Michael man taking on 31 marathons in 31 days in memory of friend
Government grant partially funded fishing vessel later used for smuggling